N. Alatrakchi

发表

Dynamic changes in innate immune responses during direct‐acting antiviral therapy for HCV infection

G. Lauer, R. Chung, P. Tonnerre, 2019, Journal of viral hepatitis.

The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial

M. Lederman, J. Mellors, J. Coffin, 2010, PLoS medicine.

Fatty Acids Activate the Transcriptional Coactivator YAP1 to Promote Liver Fibrosis via p38 Mitogen-Activated Protein Kinase

Wenyu Lin, R. Chung, S. Shroff, 2021, Cellular and molecular gastroenterology and hepatology.

Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types

M. Yarmush, Wenyu Lin, C. Brisac, 2016, Hepatology.

HCV in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types

M. Yarmush, Wenyu Lin, R. Chung, 2016 .

A tale of two viruses: hepatitis C in the age of HAART

M. Koziel, N. Alatrakchi, 2003, The Lancet.

Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet‐induced mouse model of nonalcoholic steatohepatitis

R. Chung, P. Caravan, B. Fuchs, 2018, Hepatology communications.

Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease

Jessica L. Mueller, R. Chung, J. Misdraji, 2015, Clinical and Translational Gastroenterology.

Circulating Soluble CD 163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease

Jessica L. Mueller, R. Chung, J. Misdraji, 2015 .

Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial

A. Giobbie-Hurder, G. Dranoff, J. Ritz, 2017, Clinical Cancer Research.

Bregs in Chronic HBV: Is It Time for Bragging Rights?

N. Alatrakchi, 2015, Digestive Diseases and Sciences.

Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection

R. Chung, S. Deeks, K. Corey, 2018, The Journal of infectious diseases.

Ex vivo analysis of resident hepatic pro‐inflammatory CD1d‐reactive T cells and hepatocyte surface CD1d expression in hepatitis C

D. Schuppan, M. Exley, H. Rosen, 2013, Journal of viral hepatitis.

Hepatitis C Virus (HCV)-Specific CD8+ Cells Produce Transforming Growth Factor β That Can Suppress HCV-Specific T-Cell Responses

K. Sherman, M. Exley, H. V. D. van der Vliet, 2007, Journal of Virology.

Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defects.

S. Balk, L. Lynch, M. Exley, 2011, Clinical immunology.

T‐Cell Clonal Expansion in Patients with B‐Cell Lymphoproliferative Disorders

E. Frau, P. Carde, F. Farace, 1998, Journal of immunotherapy.

Antiviral T-cell responses and therapy in chronic hepatitis B.

M. Koziel, N. Alatrakchi, 2003, Journal of hepatology.

Regulatory T cells and viral liver disease

M. Koziel, N. Alatrakchi, 2009, Journal of viral hepatitis.

CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection.

K. Sherman, C. Graham, M. Koziel, 2005, The Journal of infectious diseases.

Clinical implementation of single-cell RNA sequencing using liver fine needle aspirate tissue sampling and centralized processing captures compartment specific immuno-diversity

N. Hacohen, Alex S Genshaft, A. Shalek, 2021, bioRxiv.

Differentiation of exhausted CD8+ T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memory

Todd M. Allen, N. Hacohen, T. Eisenhaure, 2021, Nature Immunology.

Differentiation of exhausted CD8 T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memory

Todd M. Allen, N. Hacohen, T. Eisenhaure, 2021, Nature Immunology.

Decreased frequencies of virus-specific T helper type 1 cells during interferon alpha plus ribavirin treatment in HIV–hepatitis C virus co-infection

C. Katlama, B. Autran, T. Poynard, 2003, AIDS.

IQGAP2 is a novel interferon-alpha antiviral effector gene acting non-conventionally through the NF-κB pathway.

Wenyu Lin, R. Chung, C. Brisac, 2016, Journal of hepatology.

Prognostic value of CA 15.3 kinetics for metastatic breast cancer.

B De La Lande, K Hacene, J L Floiras, 2002, The International journal of biological markers.

Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication

V. Calvez, A. Samri, C. Katlama, 2005, AIDS.

Hepatitis c virus‐specific t‐cell‐derived transforming growth factor beta is associated with slow hepatic fibrogenesis

D. Schuppan, N. Afdhal, Y. Popov, 2012, Hepatology.

Proliferative, IFNγ and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection

F. Brun-Vézinet, G. Carcelain, B. Autran, 2006, AIDS.

Single-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis.

N. Hacohen, R. Mylvaganam, G. Lauer, 2023, Journal of hepatology.

Strong CD4 Th1 responses to HIV and hepatitis C virus in HIV-infected long-term non-progressors co-infected with hepatitis C virus

B. Autran, V. Thibault, V. Di Martino, 2002, AIDS.

LOXL-2 and TNC-C are markers of liver fibrogenesis in HCV/HIV-, HIV- and HCV-infected patients.

G. Lauer, Wenyu Lin, S. Deeks, 2022, Biomarkers in medicine.

Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease

R. Chung, J. Misdraji, Lindsay Y King, 2015, Clinical and Translational Gastroenterology.

Prognostic Value of CA 15.3 Kinetics for Metastatic Breast Cancer

M. Pichon, N. Alatrakchi, B. de la Lande, 2002 .

Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients

N. Hacohen, Alex S Genshaft, A. Shalek, 2023, Hepatology.